Identification of new snake venom metalloproteinase inhibitors using compound screening and rational peptide design

ACS Medicinal Chemistry Letters

Volumn 3, Issue 7, 2012, Pages 540-543

  Villalta Romero, Fabián ^a   Gortat, Anna ^b   Herrera, Andrés E ^b   Arguedas, Rebeca ^a,e   Quesada, Javier ^a   De Melo, Robson Lopes ^c   Calvete, Juan J ^d   Montero, Mavis ^a   Murillo, Renato ^a   Rucavado, Alexandra ^a   Gutiérrez, José María ^a   Pérez Payá, Enrique ^b,d  

^a UNIVERSIDAD DE COSTA RICA   (Costa Rica)

^b CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

^c INSTITUTO BUTANTAN   (Brazil)

^d CSIC   (Spain)

^e Centro Nacional de Alta Tecnología   (Costa Rica)

Author keywords

BaP1; metalloproteinase inhibitors; protein docking; snake venom metalloproteinases

Indexed keywords

BATIMASTAT; HARMALINE HYDROCHLORIDE DIHYDRATE; METALLOPROTEINASE INHIBITOR; NITROFURAL; PEPTIDOMIMETIC AGENT; PHENAZOPYRIDINE; SNAKE VENOM; UNCLASSIFIED DRUG;

ARTICLE; DRUG DESIGN; DRUG IDENTIFICATION; DRUG SCREENING; PRIORITY JOURNAL; SNAKEBITE;

BOTHROPS ASPER; VIPERIDAE;

EID: 84863855304     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml300068r     Document Type: Article

References (19)

1. Warrell, D. A. Snake bite Lancet 2010, 375, 77-88
2. Gutierrez, J. M.; Rucavado, A.; Chaves, F.; Diaz, C.; Escalante, T. Experimental pathology of local tissue damage induced by Bothrops asper snake venom Toxicon 2009, 54, 958-975
3. Gutierrez, J. M.; Theakston, R. D.; Warrell, D. A. Confronting the neglected problem of snake bite envenoming: The need for a global partnership PLoS Med. 2006, 3, e150
4. Coussens, L. M.; Fingleton, B.; Matrisian, L. M. Matrix metalloproteinase inhibitors and cancer: trials and tribulations Science 2002, 295, 2387-2392
5. Jacobsen, F. E.; Lewis, J. A.; Cohen, S. M. The design of inhibitors for medicinally relevant metalloproteins ChemMedChem 2007, 2, 152-171
6. Lingott, T.; Schleberger, C.; Gutierrez, J. M.; Merfort, I. High-resolution crystal structure of the snake venom metalloproteinase BaP1 complexed with a peptidomimetic: Insight into inhibitor binding Biochemistry 2009, 48, 6166-6174
7. Lukacova, V.; Zhang, Y.; Mackov, M.; Baricic, P.; Raha, S.; Calvo, J. A.; Balaz, S. Similarity of binding sites of human matrix metalloproteinases J. Biol. Chem. 2004, 279, 14194-14200
8. Puerta, D. T.; Cohen, S. M. Examination of novel zinc-binding groups for use in matrix metalloproteinase inhibitors Inorg. Chem. 2003, 42, 3423-3430
9. Watanabe, L.; Shannon, J. D.; Valente, R. H.; Rucavado, A.; Alape-Giron, A.; Kamiguti, A. S.; Theakston, R. D.; Fox, J. W.; Gutierrez, J. M.; Arni, R. K. Amino acid sequence and crystal structure of BaP1, a metalloproteinase from Bothrops asper snake venom that exerts multiple tissue-damaging activities Protein Sci. 2003, 12, 2273-2281
10. Pratt, L. M.; Beckett, R. P.; Bellamy, C. L.; Corkill, D. J.; Cossins, J.; Courtney, P. F.; Davies, S. J.; Davidson, A. H.; Drummond, A. H.; Helfrich, K.; Lewis, C. N.; Mangan, M.; Martin, F. M.; Miller, K.; Nayee, P.; Ricketts, M. L.; Thomas, W.; Todd, R. S.; Whittaker, M. The synthesis of novel matrix metalloproteinase inhibitors employing the Ireland-Claisen rearrangement Bioorg. Med. Chem. Lett. 1998, 8, 1359-1364
11. Fisher, J. F.; Mobashery, S. Recent advances in MMP inhibitor design Cancer Metastasis Rev. 2006, 25, 115-136
12. Gutierrez, J. M.; Rucavado, A.; Ovadia, M. Metalloproteinase inhibitors in snakebite envenomations Drug Discovery Today 1999, 4, 532-533
13. Howes, J. M.; Theakston, R. D.; Laing, G. D. Neutralization of the haemorrhagic activities of viperine snake venoms and venom metalloproteinases using synthetic peptide inhibitors and chelators Toxicon 2007, 49, 734-739
14. Escalante, T.; Franceschi, A.; Rucavado, A.; Gutierrez, J. M. Effectiveness of batimastat, a synthetic inhibitor of matrix metalloproteinases, in neutralizing local tissue damage induced by BaP1, a hemorrhagic metalloproteinase from the venom of the snake bothrops asper Biochem. Pharmacol. 2000, 60, 269-274
15. Suter, D. M.; Preynat-Seauve, O.; Tirefort, D.; Feki, A.; Krause, K. H. Phenazopyridine induces and synchronizes neuronal differentiation of embryonic stem cells J. Cell Mol. Med. 2009, 13, 3517-3527
16. Steinman, D. H.; Curtin, M. L.; Garland, R. B.; Davidsen, S. K.; Heyman, H. R.; Holms, J. H.; Albert, D. H.; Magoc, T. J.; Nagy, I. B.; Marcotte, P. A.; Li, J.; Morgan, D. W.; Hutchins, C.; Summers, J. B. The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors Bioorg. Med. Chem. Lett. 1998, 8, 2087-2092
17. Valente, R. H.; Dragulev, B.; Perales, J.; Fox, J. W.; Domont, G. B. BJ46a, a snake venom metalloproteinase inhibitor. Isolation, characterization, cloning and insights into its mechanism of action Eur. J. Biochem. 2001, 268, 3042-3052
18. Hu, X.; Shelver, W. H. Docking studies of matrix metalloproteinase inhibitors: Zinc parameter optimization to improve the binding free energy prediction J. Mol. Graphics Modell. 2003, 22, 115-126
19. Peterson, Q. P.; Goode, D. R.; West, D. C.; Ramsey, K. N.; Lee, J. J.; Hergenrother, P. J. PAC-1 activates procaspase-3 in vitro through relief of zinc-mediated inhibition J. Mol. Biol. 2009, 388, 144-158